...
...
Next Story

‘Precautionary dose' applicable after 9 months of 2nd dose of Covid vaccine: NHA

Sharma, who also heads the functioning of the CoWIN platform, further explained the need for a comorbidity certificate from a registered physician for the third shot.

Published on: Dec 27, 2021, 18:13:36 IST
Written by | Edited by , New Delhi
Prefer HTon Google
Advertisement

The National Health Authority (NHA) said on Monday that healthcare workers and those above the age of 60 will be eligible for a 'precautionary dose' of vaccine against Covid-19 only after nine months of receiving the second jab.

Sharma, who also heads the functioning of the CoWIN platform, further explained the need for a comorbidity certificate from a registered physician for the third shot. (Representational image)
Sharma, who also heads the functioning of the CoWIN platform, further explained the need for a comorbidity certificate from a registered physician for the third shot. (Representational image)

"When you are more than 60 years of age and you have already been given two doses and if you want to register for the third dose, the gap between the second dose and the day you are registering or the day you are getting the third dose should be more than nine months which is 39 weeks," news agency ANI quoted Dr RS Sharma, the chief executive officer of NHA, as saying.

Sharma, who also heads the functioning of the CoWIN platform, further explained the need for a comorbidity certificate from a registered physician for the third shot.

Also read | What is ‘precaution dose’ for Covid? Which vaccine will be administered?

In a televised address on December 25, Prime Minister Narendra Modi said the country would begin administering 'precautionary doses' to those above the age of 60 and suffering from co-morbidities from January 10, next year. Children aged 15-18 will also be eligible for the Covid-19 vaccine from January 3.

Also read | 60+ likely to need co-morbidity certificate for third shot: Officials

According to reports, Bharat Biotech's Covaxin, which has been granted approval for restricted use in an emergency situation in the age group between 12 and 18 years, is likely to be the only vaccine available for children.

The key decisions came amid growing concerns over a third wave of the Covid-19 pandemic which, experts fear, will be fuelled by the Omicron variant of coronavirus.

The Omicron's national tally has crossed 400.

 
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe